Article Text

Download PDFPDF
Rare cause of liver lesion in a patient with ulcerative colitis
  1. Cong Dai,
  2. Yu-hong Huang
  1. Department of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China
  1. Correspondence to Professor Cong Dai, Department of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China; congdai2006{at}sohu.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Clinical presentation

A 26-year-old man was diagnosed with a 4-month history of ulcerative colitis. At the time of diagnosis, an abdominal CT showed a thickened colorectum (figure 1A) and a normal liver (figure 1B). He was started on mesalazine 4 g/day and received this for approximately 2 months without therapeutic benefit. He clinically deteriorated and was admitted to the hospital with a fever of up to 38.5°C daily, abdominal pain and diarrhoea. Laboratory findings revealed significantly elevated white blood cells (13.86×109/L), C reactive protein (69.5 mg/L) and elevated liver enzymes: aspartate aminotransferase 245 U/L, alanine aminotransferase 368 U/L (normal <50 U/L), γ-glutamyltransferase 672 U/L (normal <60 U/L) and alkaline phosphatase 418 U/L (normal range 40–129 U/L). There was no evidence of a recent infection with malaria, Lyme disease, hepatitis A, B, C or …

View Full Text

Footnotes

  • Contributors CD and Y-hH had the original idea for the paper and were in charge of the treatment and management of the patient. CD wrote the paper and incorporated the comments from other authors. All authors reviewed and approved the final draft of the paper.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.